Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 677

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 677
---
 closing of the Mergers |

| (2) | Excludes (i) 6,403,818 shares underlying the options issued to TuHURA stockholders, (ii) 9,213,983 shares underlying the warrants issued to TuHURA stockholders and Note holders in connection with the Kintara Merger, and (iii) 1,539,958 shares underlying the CVR Agreement |

| (3) | Includes (i) 2,738,751 shares assumed to be issued as the “Initial Share Consideration” share component of the aggregate Merger Consideration in the Mergers, after taking into account the estimated Deficit Cash Consideration, and (ii) 1,129,884 shares issued as the “Kineta Delayed Share Consideration” share component of the aggregate Merger Consideration in the Mergers for historical Kineta common stockholders based on their pro rata share of Kineta’s historical equity (based on the number of Kineta fully diluted shares held by them at the Effective Time) |

The cash component of the aggregate Merger Consideration in the Mergers will be a base cash amount of approximately $6,000,000 (consisting of a value of $12,000,000 minus the approximate $6,744,503 advanced to Kineta under the Exclusivity, Right of First Offer, Existing Advances included in the CTF Agreement, and Loaned Amounts assumed through the Closing Date for working capital needs pursuant to the Merger Agreement) less the sum of Kineta’s working capital deficit at the closing of the Proposed Transaction. The share component of the aggregate Merger Consideration in the Mergers will consist of an aggregate maximum of up to approximately 3,998,051 shares of TuHURA common stock (currently estimated to be approximately 3,868,635 shares based on certain adjustments assumed herein to the Initial Share Consideration, including an estimated $744,503 Deficit Cash Consideration), subject to a six-monthholdback of approximately 1,129,884 of such shares to satisfy certain additional liabilities of the closing date that may be identified after the closing. As additional Merger Consideration in the Mergers, Kineta stockholders will be entitled to receive their pro rata share of certain payments that Kineta may receive after the closing from the potential pre-closingsale by Kineta of certain non-KVA12123products and technologies.

441

### NOTES TO UNAUDITED PRO FORM